The results of this call for evidence will inform the development of the next 5-year national action plan (NAP) on antimicrobial resistance (AMR), which will run from 2024 to 2029.
The 2024 to 2029 NAP will continue being developed in consultation with a broad range of stakeholders across different sectors. It will build on the achievements of the 2019 to 2024 NAP, while recognising where there is more for us to do, and it will be aligned with global plans and frameworks for action.
The call for evidence asked questions designed to understand:
- changes in the risk landscape
- progress on tackling AMR to date
- key interventions the government should consider
You can find the response here.
